Literature DB >> 3879242

Cyclosporin partitions into phospholipid vesicles and disrupts membrane architecture.

M Haynes, L Fuller, D H Haynes, J Miller.   

Abstract

Cyclosporin is a fungal metabolite demonstrating potent immunosuppressive activity both in vitro and in vivo, but the mechanism of action is poorly understood. Using [3H]dihydrocyclosporin C ([3H]CsC) we observed significant binding by mononuclear cells, erythrocytes and phosphatidyl choline (PC) vesicles which was reversible by the addition of excess CsA. Trypsin, pronase or heat treatments demonstrated that B cells and adherent cells express a protease-sensitive membrane binding site not observed on T cells. The nature of the interaction between CsA and the PC vesicles was studied using the membrane surface probe 1-anilino-8-naphthyl sulfonic acid (ANS-). ANS- -induced fluorescence was reduced by 24% in the presence of 4.75 X 10(-7). M CsA indicating that CsA displaces ANS- from the PC vesicles. CsA also effected a shift in the phase transition temperature of PC vesicles from 23 degrees C to 19 degrees C. Finally, the rate of concanavalin A (Con A)-induced cap formation by T lymphocytes was approximately doubled in the presence of 2.6 X 10(-5) M CsA. These data demonstrate that CsA partitions into phospholipid vesicle membranes and the plasmalemma of mononuclear cells resulting in an increased membrane fluidity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3879242     DOI: 10.1016/0165-2478(85)90118-x

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  8 in total

1.  Characterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiology.

Authors:  J A Silverman; M L Hayes; B J Luft; K A Joiner
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

2.  Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes.

Authors:  Oscar Marchetti; Philippe Moreillon; Josè M Entenza; Jacques Vouillamoz; Michel P Glauser; Jacques Bille; Dominique Sanglard
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

3.  Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans.

Authors:  O Marchetti; P Moreillon; M P Glauser; J Bille; D Sanglard
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

4.  Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans.

Authors:  O Marchetti; J M Entenza; D Sanglard; J Bille; M P Glauser; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

5.  Dose response of fish oil versus safflower oil on graft arteriosclerosis in rabbit heterotopic cardiac allografts.

Authors:  K L Yun; J I Fann; M H Sokoloff; L G Fong; G E Sarris; M E Billingham; D C Miller
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

6.  Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells.

Authors:  H J Broxterman; H M Pinedo; G J Schuurhuis; J Lankelma
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

7.  Effects of cyclosporin A and a non-immunosuppressive analogue, O-acetyl cyclosporin A, upon the growth of parent and multidrug resistant human lung cancer cells in vitro.

Authors:  P R Twentyman; K A Wright; H M Wallace
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

8.  Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes.

Authors:  S Yano; S Sone; Y Nishioka; M Naito; T Tsuruo; T Ogura
Journal:  Jpn J Cancer Res       Date:  1994-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.